Publication | Closed Access
Phase II study of docetaxel plus cisplatin as a second-line combined therapy in patients with advanced gastric carcinoma.
31
Citations
0
References
2005
Year
This combination therapy was effective as a second-line treatment for advanced gastric cancer with acceptable toxic side-effects.